Physician profile
Russel Novak
NPI 1003973645
$3,048.81
in general payments reported to CMS, 2019-2025
13 companies · $998 in 2025
The $998 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.41 · 2021: $265 · 2022: $1,052 · 2023: $419 · 2024: $217 · 2025: $998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,634.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,307.29 | 2022-2025 | Tisseel, Floseal |
| Tela Bio, INC. | $331.94 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $321.68 | 2019-2025 | Phasix Mesh |
| Medtronic, INC. | $305.75 | 2025 | Signia |
| Hologic Sales and Service, LLC | $251.51 | 2023-2025 | Magtrace, Sentimag, Trunode |
| Intuitive Surgical, INC. | $139.14 | 2021 | |
| Smith+Nephew, INC. | $127.41 | 2024-2025 | Stravix, Grafix Pl, Pico 14 |
| Olympus America INC. | $125.40 | 2021 | |
| Ethicon US, LLC | $38.06 | 2022-2024 | Dermabond Prineo, Echelon Circular, Vistaseal |
| Conmed Corporation | $35.76 | 2024 | Airseal |
| Aroa Biosurgery Incorporated | $25.15 | 2025 | |
| Mimedx Group, INC. | $21.49 | 2024 | |
| Merit Medical Systems INC | $18.23 | 2025 | Savi Scout |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russel Novak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.